跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
INTRAROSA
Authorized
STANDARD
INTRAROSA
COSETTE PHARMACEUTICALS, INC.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
6c5648a3e990b501
Company
COSETTE PHARMACEUTICALS, INC.
Type
Standard
Approval Details
Approval Id
6c5648a3e990b501
Drug Approval Canada Name
INTRAROSA
Product Name
INTRAROSA
Status
Marketed
Status Date
2024-05-28
Original Market Date
2022-09-02
Din
02493500
Drug Class
Human
Dosage Form
Ovule
Route Of Administration
Vaginal
Schedule
Schedule G (CDSA IV)
Ahfs
68:08.00
Atc Original
G03XX01 PRASTERONE
Atc Name
g 03 xx 01
Aig Number
0161950001
Company Name
COSETTE PHARMACEUTICALS, INC.
Company Address
101 Coolidge Street, South Plainfield, New Jersey, United States, 07080
Company Detail Path
/organization/cosette-pharmaceuticals-inc
Company Information
Pharmaceutical Company Name
COSETTE PHARMACEUTICALS, INC.
Country Name
United States
Province Name
New Jersey
City Name
bridgewater,new jersey,country_us
Address
200 Crossing Blvd FL 4
Active Ingredients
PRASTERONE
6.5 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
6c5648a3e990b501
Type
Standard
Back to Health Canada Approvals
INTRAROSA - Health Canada Drug Approval Details